Filing Details
- Accession Number:
- 0001127602-10-001219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-08 12:00:00
- Reporting Period:
- 2010-01-07
- Filing Date:
- 2010-01-08
- Accepted Time:
- 2010-01-08 16:44:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231589 | A Paul Mahon | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-07 | 4,000 | $27.97 | 29,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-01-07 | 4,000 | $53.22 | 25,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-01-07 | 200 | $30.75 | 25,700 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-01-07 | 200 | $53.22 | 25,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2010-01-07 | 4,000 | $0.00 | 4,000 | $27.97 |
| Common Stock | Stock Options | Disposition | 2010-01-07 | 200 | $0.00 | 200 | $30.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 69,000 | 2008-03-15 | 2007-03-15 | No | 4 | M | Direct |
| 88,550 | 2017-09-14 | No | 4 | M | Direct |
Footnotes
- The exercise of stock options and the corresponding sale of 4,000 shares are pursuant to the 10b5-1 Plan adopted by the reporting person on May 6, 2009.
- This exercise of stock options and corresponding sale of 200 shares was pursuant to a 10b5-1 Plan entered into by the reporting person on May 6, 2009.
- These stock options became exercisable on 12/26/2009.
Billionaire Hedge Funds
